Di-substituted oxadiazoles as CXC-chemokine receptor ligands
US7718678B2 · kind B2 · utility
7Cited by
37References
42Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 27, 2006 |
| Grant date | May 18, 2010 |
| Priority date | — |
| Expiry date | Aug 6, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are compounds of the formulaand the pharmaceutically acceptable salts thereof. X is N or N+O−, and Y is N or N+O−, provided that at least X or Y is N. The compounds are useful for the treatment of chemokine-mediated diseases such as COPD.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.